Dr Tamera Corte

BSc(Med) MBBS(Hons) FRACP PhD
Clinical Associate Professor, Central Clinical School

Telephone 95156120

Map

Selected grants

2018

  • Circulatory biomarkers for Idiopathic Pulmonary Fibrosis: improving patient outcomes; Corte T, Moodley Y, Knight D, Reynolds P, Walters E, Glaspole I, Allan H; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Ambulatory oxygen for interstitial lung disease; Holland A, Corte T; National Health and Medical Research Council (NHMRC)/Project Grants.

2017

  • Centre for Research Excellence in Pulmonary Fibrosis; Corte T, Knight D, Laurent G, Holland A, Chambers D, Moodley Y, Walters E, Westall G, Glaspole I, Palmer A; National Health and Medical Research Council (NHMRC)/Centres of Research Excellence.

2016

  • Occupational and Environmental Exposures Associated with Idiopathic Pulmonary Fibrosis in Australia; Abramson M, Corte T; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • Identification of Progressive Disease in Idiopathic Pulmonary Fibrosis; Corte T, Walters E, Reynolds P, Moodley Y, Hopkins P, Goh N, Glaspole I, Zappala C; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • NOVEL NON-INVASIVE METHODS FOR THE EARLY DETECTION OF PULMONARY VASCULAR DISEASE; Celermajer D, Corte T, Bailey D; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Jo, H., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Corte, T., et al (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. B M C Pulmonary Medicine, 18(1), 1-8. [More Information]
  • Corte, T., Collard, H., Wells, V. (2017). A new era in idiopathic interstitial pneumonias: Epilogue to a review series. Respirology, 22(1), 14-16. [More Information]
  • Ryerson, C., Corte, T., Lee, J., Richeldi, L., Walsh, S., Myers, J., Behr, J., Cottin, V., Danoff, S., Flaherty, K., et al (2017). A standardized diagnostic ontology for fibrotic interstitial lung disease an international working group perspective. American Journal of Respiratory and Critical Care Medicine, 196(10), 1249-1254. [More Information]
  • Jo, H., Glaspole, I., Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Cooper, W., Corte, T., et al (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal, 49(2), 1-11. [More Information]
  • Cheng, J., Wilcox, P., Glaspole, I., Corte, T., Murphy, D., Hague, C., Ryerson, C. (2017). Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology, 22(8), 1592-1597. [More Information]
  • Glaspole, I., Watson, A., Allan, H., Chapman, S., Cooper, W., Corte, T., Ellis, S., Grainge, C., Goh, N., Hopkins, P., Mahar, A., et al (2017). Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis. European Respiratory Journal, 50(2), pii: 1700168. [More Information]
  • Walsh, S., Maher, T., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., Vancheri, C., Wilsher, M., Antoniou, K., Corte, T., et al (2017). Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study. European Respiratory Journal, 50(2), 1-10. [More Information]
  • Glaspole, I., Chapman, S., Cooper, W., Ellis, S., Goh, N., Hopkins, P., Macansh, S., Mahar, A., Moodley, Y., Paul, E., Corte, T., et al (2017). Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry. Respirology, 22(5), 950-956. [More Information]
  • Jee, A., Jo, H., Corte, T. (2017). Hypersensitivity pneumonitis: A protean and challenging disease. Respirology, 22(8), 1489-1490. [More Information]
  • Jo, H., Corte, T. (2017). Nintedanib for idiopathic pulmonary fibrosis in the Japanese population. Respirology, 22(4), 630-631. [More Information]
  • Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
  • Kreuter, M., Bendstrup, E., Russell, A., Bajwah, S., Lindell, K., Adir, Y., Brown, C., Calligaro, G., Cassidy, N., Corte, T., et al (2017). Palliative care in interstitial lung disease: living well. The Lancet Respiratory Medicine, 5(12), 968-980. [More Information]
  • Ryerson, C., Corte, T., Martinez, F., Collard, H. (2017). Reply. American Journal of Respiratory and Critical Care Medicine, 195(2), 269-269.
  • Corte, T., Ryerson, C., Collard, H. (2017). Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 195(4), 542-543. [More Information]
  • Ryerson, C., Corte, T., Martinez, F., Collard, H. (2017). Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air. American Journal of Respiratory and Critical Care Medicine, 195(2), 269-269. [More Information]
  • Jee, A., Adelstein, S., Bleasel, J., Keir, G., Nguyen, M., Sahhar, J., Youssef, P., Corte, T. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6(5), 1-23. [More Information]
  • Prasad, J., Mahar, A., Bleasel, J., Ellis, S., Chambers, D., Lake, F., Hopkins, P., Corte, T., Allan, H., Glaspole, I. (2017). The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1459-1472. [More Information]
  • Stanton, K., Ganigara, M., Corte, P., Celermajer, D., McGuire, M., Torzillo, P., Corte, T., Puranik, R. (2017). The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis. Heart, Lung and Circulation, 26(11), 1191-1199. [More Information]
  • Jo, H., Troy, L., Keir, G., Chambers, D., Holland, A., Goh, N., Wilsher, M., De Boer, S., Moodley, Y., Grainge, C., Corte, T., et al (2017). Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1436-1458. [More Information]
  • Jee, A., Corte, T., Wort, S., Eves, N., Wainwright, C., Piper, A. (2017). Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep. Respirology, 22(5), 1022-1034. [More Information]
  • Jee, A., Bleasel, J., Adelstein, S., Keir, G., Corte, T. (2016). A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. European Respiratory Journal, 48(6), 1811-1813. [More Information]
  • Collard, H., Ryerson, C., Corte, T., Jenkins, G., Kondoh, Y., Lederer, D., Lee, J., Maher, T., Wells, A., et al (2016). Acute exacerbation of idiopathic pulmonary fibrosis: An international working group report. American Journal of Respiratory and Critical Care Medicine, 194(3), 265-275. [More Information]
  • Jo, H., Glaspole, I., Levin, K., McCormack, S., Mahar, A., Cooper, W., Cameron, R., Ellis, S., Cottee, A., Troy, L., Torzillo, P., Corte, T., et al (2016). Clinical impact of the interstitial lung disease multidisciplinary service. Respirology, 21(8), 1438-1444. [More Information]
  • Jo, H., Corte, T., Moodley, Y., Levin, K., Westall, G., Hopkins, P., Chambers, D., Glaspole, I. (2016). Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. B M C Pulmonary Medicine, 16(1), 1-6. [More Information]
  • Troy, L., Young, I., Lau, E., Corte, T. (2016). Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia. Respirology, 21(6), 1005-1014. [More Information]
  • Jo, H., Randhawa, S., Corte, T., Moodley, Y. (2016). Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs and Aging, 33(5), 321-334. [More Information]
  • Jo, H., Corte, T., Wort, S., Eves, N., Piper, A., Wainwright, C. (2016). Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease. Respirology, 21(3), 556-566. [More Information]
  • Troy, L., Chapman, S., Lake, F., Wilsher, M., Honeysett, L., Macansh, S., Corte, T. (2015). Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now? Respirology, 20(4), 647-653. [More Information]
  • Moodley, Y., Corte, T., Richeldi, L., King Jr, T. (2015). Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective. Respirology, 20(3), 389-394. [More Information]
  • Corte, T., Collard, H., Wells, A. (2015). Idiopathic interstitial pneumonias in 2015: A new era. Respirology, 20(5), 697-698. [More Information]
  • Troy, L., Corte, T. (2015). Interstitial lung disease in 2015: Where are we now? Australian Family Physician, 44(8), 546-552.
  • Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., Morrisroe, K., Thakkar, V., Sahhar, V., Roddy, J., Youssef, P., et al (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(Suppl 91), S111-S116.
  • Corte, T., Bonella, F., Crestani, B., Demedts, M., Richeldi, L., Coeck, C., Peling, K., Quaresma, M., Lasky, J. (2015). Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis. Respiratory Research (Online), 16(1), 1-10. [More Information]
  • Troy, L., Corte, T. (2015). Therapy for idiopathic pulmonary fibrosis: lessons from pooled data analyses. European Respiratory Journal, 47(1), 27-30. [More Information]
  • Ryerson, C., Corte, T., Collard, H., Richeldi, L. (2014). A global registry for idiopathic pulmonary fibrosis: the time is now. European Respiratory Journal, 44(2), 273-276. [More Information]
  • Moodley, Y., Goh, N., Glaspole, I., Macansh, S., Walters, E., Chapman, S., Hopkins, P., Reynolds, P., Zappala, C., Cooper, W., Mahar, A., Corte, T., et al (2014). Australian Idiopathic Pulmonary Fibrosis Registry: Vital lessons from a national prospective collaborative project. Respirology, 19(7), 1088-1091. [More Information]
  • Corte, T., Keir, G., Dimopoulos, K., Howard, L., Corris, P., Parfitt, L., Foley, C., Yanez-Lopez, M., Babalis, D., Marino, P., et al (2014). Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine, 190(2), 208-217. [More Information]
  • Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
  • Jaffar, J., Unger, S., Corte, T., Keller, M., Wolters, P., Richeldi, L., Cerri, S., Prele, C., Hansbro, P., Argraves, W., Oliver, B., Black, J., Burgess, J., et al (2014). Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis. Chest, 146(4), 1055-1063. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
  • Troy, L., Corte, T. (2014). Sleep disordered breathing in interstitial lung disease: A review. World Journal of Clinical Cases, 2(12), 828-834. [More Information]
  • Troy, L., Hamor, P., Bleasel, J., Corte, T. (2014). Two simultaneous autoimmune processes in a patient presenting with respiratory insufficiency. Respirology Case Reports, 2(1), 21-23. [More Information]
  • Corte, T., Goh, N., Glaspole, I., Zappala, C., Hopkins, P., Wilsher, M. (2013). Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials? Thorax, 68(5), 491-492. [More Information]
  • Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Internal Medicine Journal, 42(12), 1351-1354. [More Information]
  • Troy, L., Corte, T. (2012). Management of the idiopathic interstitial pneumonias. Australian Prescriber, 35(6), 202-206.
  • Corte, T., Wort, S., Macdonald, P., Edey, A., Hansell, D., Renzoni, E., Maher, T., Nicholson, A., Bandula, S., Bresser, P., et al (2012). Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology, 17(4), 674-680. [More Information]
  • Lau, E., Corte, T. (2012). Pulmonary hypertension in 2012: contemporary issues in diagnosis and management. Panminerva Medica, 54(1), 11-28. [More Information]
  • Corte, T., McDonagh, T., Wort, S. (2012). Pulmonary hypertension in left heart disease: A review. International Journal of Cardiology, 156(3), 253-258. [More Information]
  • Corte, T., Copley, S., Desai, S., Zappala, C., Hansell, D., Nicholson, A., Colby, T., Renzoni, E., Maher, T., Wells, A. (2012). Significance of connective tissue disease features in idiopathic interstitial pneumonia. European Respiratory Journal, 39(3), 661-668. [More Information]
  • Keir, G., Corte, T. (2011). Pulmonary Hypertension in Interstitial Lung Disease: A Review. Clinical Pulmonary Medicine, 18(5), 222-229. [More Information]
  • Devaraj, A., Wells, A., Meister, M., Corte, T., Wort, S., Hansell, D. (2010). Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology, 254(2), 609-616. [More Information]
  • Corte, T., Wort, S., Gatzoulis, M., Engel, R., Giannakoulas, G., MacDonald, P., Wells, A. (2010). Elevated brain natriuretic peptide predicts mortality in interstitial lung disease. European Respiratory Journal, 36(4), 819-825. [More Information]
  • Corte, T., Wells, A., Gatzoulis, M., Cramer, D., Ward, S., MacDonald, P., Dimopoulos, K., Wort, S. (2010). Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung disease. Thorax, 65(4), 341-345. [More Information]
  • Corte, T., Gatzoulis, M., Parfitt, L., Harries, C., Wells, A., Wort, S. (2010). The use of Sildenafil to treat pulmonary hypertension associated with interstitial lung disease. Respirology, 15(8), 1226-1232. [More Information]
  • Corte, T., Wort, S., Gatzoulis, M., MacDonald, P., Hansell, D., Wells, A. (2009). Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax, 64(10), 883-888. [More Information]
  • Corte, T., Wort, S. (2009). Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease. Clinical Science, 116(6), 493-495. [More Information]
  • Corte, T., Wells, A. (2009). Treatment of idiopathic interstitial pneumonias. Expert Review of Respiratory Medicine, 3(1), 81-91. [More Information]
  • Corte, T., Ellis, R., Renzoni, E., Nicholson, A., du Bois, R., Wells, A. (2009). Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 26(2), 132-138. [More Information]
  • Goh, N., Desai, S., Hansell, D., Copley, S., Maher, T., Corte, T., Sander, C., Ratoff, J., Devaraj, A., Bozovic, G., et al (2008). Interstitial lung disease in systemic sclerosis: a simple staging system. American Journal of Respiratory and Critical Care Medicine, 177(11), 1248-1254. [More Information]
  • Devaraj, A., Wells, A., Meister, M., Corte, T., Hansell, D. (2008). The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology, 249(3), 1042-1049. [More Information]
  • Corte, T., Tattersall, S. (2006). Iron deficiency anaemia: a presentation of idiopathic pulmonary haemosiderosis. Internal Medicine Journal, 36(3), 207-9. [More Information]

2018

  • Jo, H., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Corte, T., et al (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. B M C Pulmonary Medicine, 18(1), 1-8. [More Information]

2017

  • Corte, T., Collard, H., Wells, V. (2017). A new era in idiopathic interstitial pneumonias: Epilogue to a review series. Respirology, 22(1), 14-16. [More Information]
  • Ryerson, C., Corte, T., Lee, J., Richeldi, L., Walsh, S., Myers, J., Behr, J., Cottin, V., Danoff, S., Flaherty, K., et al (2017). A standardized diagnostic ontology for fibrotic interstitial lung disease an international working group perspective. American Journal of Respiratory and Critical Care Medicine, 196(10), 1249-1254. [More Information]
  • Jo, H., Glaspole, I., Grainge, C., Goh, N., Hopkins, P., Moodley, Y., Reynolds, P., Chapman, S., Walters, E., Cooper, W., Corte, T., et al (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal, 49(2), 1-11. [More Information]
  • Cheng, J., Wilcox, P., Glaspole, I., Corte, T., Murphy, D., Hague, C., Ryerson, C. (2017). Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology, 22(8), 1592-1597. [More Information]
  • Glaspole, I., Watson, A., Allan, H., Chapman, S., Cooper, W., Corte, T., Ellis, S., Grainge, C., Goh, N., Hopkins, P., Mahar, A., et al (2017). Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis. European Respiratory Journal, 50(2), pii: 1700168. [More Information]
  • Walsh, S., Maher, T., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., Vancheri, C., Wilsher, M., Antoniou, K., Corte, T., et al (2017). Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study. European Respiratory Journal, 50(2), 1-10. [More Information]
  • Glaspole, I., Chapman, S., Cooper, W., Ellis, S., Goh, N., Hopkins, P., Macansh, S., Mahar, A., Moodley, Y., Paul, E., Corte, T., et al (2017). Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry. Respirology, 22(5), 950-956. [More Information]
  • Jee, A., Jo, H., Corte, T. (2017). Hypersensitivity pneumonitis: A protean and challenging disease. Respirology, 22(8), 1489-1490. [More Information]
  • Jo, H., Corte, T. (2017). Nintedanib for idiopathic pulmonary fibrosis in the Japanese population. Respirology, 22(4), 630-631. [More Information]
  • Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
  • Kreuter, M., Bendstrup, E., Russell, A., Bajwah, S., Lindell, K., Adir, Y., Brown, C., Calligaro, G., Cassidy, N., Corte, T., et al (2017). Palliative care in interstitial lung disease: living well. The Lancet Respiratory Medicine, 5(12), 968-980. [More Information]
  • Ryerson, C., Corte, T., Martinez, F., Collard, H. (2017). Reply. American Journal of Respiratory and Critical Care Medicine, 195(2), 269-269.
  • Corte, T., Ryerson, C., Collard, H. (2017). Reply: Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 195(4), 542-543. [More Information]
  • Ryerson, C., Corte, T., Martinez, F., Collard, H. (2017). Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air. American Journal of Respiratory and Critical Care Medicine, 195(2), 269-269. [More Information]
  • Jee, A., Adelstein, S., Bleasel, J., Keir, G., Nguyen, M., Sahhar, J., Youssef, P., Corte, T. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6(5), 1-23. [More Information]
  • Prasad, J., Mahar, A., Bleasel, J., Ellis, S., Chambers, D., Lake, F., Hopkins, P., Corte, T., Allan, H., Glaspole, I. (2017). The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1459-1472. [More Information]
  • Stanton, K., Ganigara, M., Corte, P., Celermajer, D., McGuire, M., Torzillo, P., Corte, T., Puranik, R. (2017). The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis. Heart, Lung and Circulation, 26(11), 1191-1199. [More Information]
  • Jo, H., Troy, L., Keir, G., Chambers, D., Holland, A., Goh, N., Wilsher, M., De Boer, S., Moodley, Y., Grainge, C., Corte, T., et al (2017). Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22(7), 1436-1458. [More Information]
  • Jee, A., Corte, T., Wort, S., Eves, N., Wainwright, C., Piper, A. (2017). Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep. Respirology, 22(5), 1022-1034. [More Information]

2016

  • Jee, A., Bleasel, J., Adelstein, S., Keir, G., Corte, T. (2016). A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. European Respiratory Journal, 48(6), 1811-1813. [More Information]
  • Collard, H., Ryerson, C., Corte, T., Jenkins, G., Kondoh, Y., Lederer, D., Lee, J., Maher, T., Wells, A., et al (2016). Acute exacerbation of idiopathic pulmonary fibrosis: An international working group report. American Journal of Respiratory and Critical Care Medicine, 194(3), 265-275. [More Information]
  • Jo, H., Glaspole, I., Levin, K., McCormack, S., Mahar, A., Cooper, W., Cameron, R., Ellis, S., Cottee, A., Troy, L., Torzillo, P., Corte, T., et al (2016). Clinical impact of the interstitial lung disease multidisciplinary service. Respirology, 21(8), 1438-1444. [More Information]
  • Jo, H., Corte, T., Moodley, Y., Levin, K., Westall, G., Hopkins, P., Chambers, D., Glaspole, I. (2016). Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. B M C Pulmonary Medicine, 16(1), 1-6. [More Information]
  • Troy, L., Young, I., Lau, E., Corte, T. (2016). Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia. Respirology, 21(6), 1005-1014. [More Information]
  • Jo, H., Randhawa, S., Corte, T., Moodley, Y. (2016). Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs and Aging, 33(5), 321-334. [More Information]
  • Jo, H., Corte, T., Wort, S., Eves, N., Piper, A., Wainwright, C. (2016). Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease. Respirology, 21(3), 556-566. [More Information]

2015

  • Troy, L., Chapman, S., Lake, F., Wilsher, M., Honeysett, L., Macansh, S., Corte, T. (2015). Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now? Respirology, 20(4), 647-653. [More Information]
  • Moodley, Y., Corte, T., Richeldi, L., King Jr, T. (2015). Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective. Respirology, 20(3), 389-394. [More Information]
  • Corte, T., Collard, H., Wells, A. (2015). Idiopathic interstitial pneumonias in 2015: A new era. Respirology, 20(5), 697-698. [More Information]
  • Troy, L., Corte, T. (2015). Interstitial lung disease in 2015: Where are we now? Australian Family Physician, 44(8), 546-552.
  • Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., Morrisroe, K., Thakkar, V., Sahhar, V., Roddy, J., Youssef, P., et al (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(Suppl 91), S111-S116.
  • Corte, T., Bonella, F., Crestani, B., Demedts, M., Richeldi, L., Coeck, C., Peling, K., Quaresma, M., Lasky, J. (2015). Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis. Respiratory Research (Online), 16(1), 1-10. [More Information]
  • Troy, L., Corte, T. (2015). Therapy for idiopathic pulmonary fibrosis: lessons from pooled data analyses. European Respiratory Journal, 47(1), 27-30. [More Information]

2014

  • Ryerson, C., Corte, T., Collard, H., Richeldi, L. (2014). A global registry for idiopathic pulmonary fibrosis: the time is now. European Respiratory Journal, 44(2), 273-276. [More Information]
  • Moodley, Y., Goh, N., Glaspole, I., Macansh, S., Walters, E., Chapman, S., Hopkins, P., Reynolds, P., Zappala, C., Cooper, W., Mahar, A., Corte, T., et al (2014). Australian Idiopathic Pulmonary Fibrosis Registry: Vital lessons from a national prospective collaborative project. Respirology, 19(7), 1088-1091. [More Information]
  • Corte, T., Keir, G., Dimopoulos, K., Howard, L., Corris, P., Parfitt, L., Foley, C., Yanez-Lopez, M., Babalis, D., Marino, P., et al (2014). Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine, 190(2), 208-217. [More Information]
  • Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
  • Jaffar, J., Unger, S., Corte, T., Keller, M., Wolters, P., Richeldi, L., Cerri, S., Prele, C., Hansbro, P., Argraves, W., Oliver, B., Black, J., Burgess, J., et al (2014). Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis. Chest, 146(4), 1055-1063. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
  • Troy, L., Corte, T. (2014). Sleep disordered breathing in interstitial lung disease: A review. World Journal of Clinical Cases, 2(12), 828-834. [More Information]
  • Troy, L., Hamor, P., Bleasel, J., Corte, T. (2014). Two simultaneous autoimmune processes in a patient presenting with respiratory insufficiency. Respirology Case Reports, 2(1), 21-23. [More Information]

2013

  • Corte, T., Goh, N., Glaspole, I., Zappala, C., Hopkins, P., Wilsher, M. (2013). Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials? Thorax, 68(5), 491-492. [More Information]

2012

  • Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Internal Medicine Journal, 42(12), 1351-1354. [More Information]
  • Troy, L., Corte, T. (2012). Management of the idiopathic interstitial pneumonias. Australian Prescriber, 35(6), 202-206.
  • Corte, T., Wort, S., Macdonald, P., Edey, A., Hansell, D., Renzoni, E., Maher, T., Nicholson, A., Bandula, S., Bresser, P., et al (2012). Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia. Respirology, 17(4), 674-680. [More Information]
  • Lau, E., Corte, T. (2012). Pulmonary hypertension in 2012: contemporary issues in diagnosis and management. Panminerva Medica, 54(1), 11-28. [More Information]
  • Corte, T., McDonagh, T., Wort, S. (2012). Pulmonary hypertension in left heart disease: A review. International Journal of Cardiology, 156(3), 253-258. [More Information]
  • Corte, T., Copley, S., Desai, S., Zappala, C., Hansell, D., Nicholson, A., Colby, T., Renzoni, E., Maher, T., Wells, A. (2012). Significance of connective tissue disease features in idiopathic interstitial pneumonia. European Respiratory Journal, 39(3), 661-668. [More Information]

2011

  • Keir, G., Corte, T. (2011). Pulmonary Hypertension in Interstitial Lung Disease: A Review. Clinical Pulmonary Medicine, 18(5), 222-229. [More Information]

2010

  • Devaraj, A., Wells, A., Meister, M., Corte, T., Wort, S., Hansell, D. (2010). Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology, 254(2), 609-616. [More Information]
  • Corte, T., Wort, S., Gatzoulis, M., Engel, R., Giannakoulas, G., MacDonald, P., Wells, A. (2010). Elevated brain natriuretic peptide predicts mortality in interstitial lung disease. European Respiratory Journal, 36(4), 819-825. [More Information]
  • Corte, T., Wells, A., Gatzoulis, M., Cramer, D., Ward, S., MacDonald, P., Dimopoulos, K., Wort, S. (2010). Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung disease. Thorax, 65(4), 341-345. [More Information]
  • Corte, T., Gatzoulis, M., Parfitt, L., Harries, C., Wells, A., Wort, S. (2010). The use of Sildenafil to treat pulmonary hypertension associated with interstitial lung disease. Respirology, 15(8), 1226-1232. [More Information]

2009

  • Corte, T., Wort, S., Gatzoulis, M., MacDonald, P., Hansell, D., Wells, A. (2009). Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax, 64(10), 883-888. [More Information]
  • Corte, T., Wort, S. (2009). Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease. Clinical Science, 116(6), 493-495. [More Information]
  • Corte, T., Wells, A. (2009). Treatment of idiopathic interstitial pneumonias. Expert Review of Respiratory Medicine, 3(1), 81-91. [More Information]
  • Corte, T., Ellis, R., Renzoni, E., Nicholson, A., du Bois, R., Wells, A. (2009). Use of intravenous cyclophosphamide in known or suspected, advanced non-specific interstitial pneumonia. Sarcoidosis Vasculitis and Diffuse Lung Diseases, 26(2), 132-138. [More Information]

2008

  • Goh, N., Desai, S., Hansell, D., Copley, S., Maher, T., Corte, T., Sander, C., Ratoff, J., Devaraj, A., Bozovic, G., et al (2008). Interstitial lung disease in systemic sclerosis: a simple staging system. American Journal of Respiratory and Critical Care Medicine, 177(11), 1248-1254. [More Information]
  • Devaraj, A., Wells, A., Meister, M., Corte, T., Hansell, D. (2008). The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology, 249(3), 1042-1049. [More Information]

2006

  • Corte, T., Tattersall, S. (2006). Iron deficiency anaemia: a presentation of idiopathic pulmonary haemosiderosis. Internal Medicine Journal, 36(3), 207-9. [More Information]

To update your profile click here. For support on your academic profile contact .